Circular Economy Profitability in Pharmaceutical Drug Delivery Systems: A Sustainability Framework Integrating Green Leadership and Environmental Accounting
医薬品デリバリーシステムにおける循環経済の収益性：グリーンリーダーシップと環境会計を統合した持続可能性フレームワーク (AI 翻訳)
Avinash Chopra, Sunny Gupta, Saumya Vatsyayan, Narinder Sharma
🤖 gxceed AI 要約
日本語
製薬業界における資源消費や廃棄物問題に対し、循環経済の原則とグリーンリーダーシップ、環境会計を統合した持続可能性フレームワークを提案。概念的研究であり、二次データに基づく。循環経済の導入が廃棄物削減、資源最適化、持続可能なサプライチェーン管理に寄与し、環境業績と収益性の向上につながると結論づける。
English
This conceptual study proposes a sustainability framework integrating circular economy principles, green leadership, and environmental accounting for pharmaceutical drug delivery systems. Based on secondary data, it finds that circular economy implementation reduces waste, optimizes resources, and enables sustainable supply chain management, enhancing both environmental performance and profitability.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
本論文は製薬業界のサプライチェーン持続可能性に焦点を当てているが、日本のGX文脈（例：SSBJや有報）との直接的な接点は限定的。しかし、環境会計とグリーンリーダーシップの統合は、日本企業の統合報告書における非財務情報開示の質向上に示唆を与える可能性がある。
In the global GX context
This paper contributes to global GX discourse by linking circular economy, green leadership, and environmental accounting in a sector-specific framework. It aligns with trends in sustainable supply chain management and ESG integration, though it remains conceptual rather than empirical. Practitioners may find the framework useful for strategic sustainability planning.
👥 読者別の含意
🔬研究者:Provides a conceptual model for integrating circular economy and environmental accounting in pharmaceutical supply chains, suitable for further empirical testing.
🏢実務担当者:Offers a high-level framework for aligning sustainability strategies with profitability in drug delivery systems, but lacks detailed implementation guidance.
🏛政策担当者:Highlights the role of regulatory compliance and stakeholder engagement in driving sustainable pharmaceutical transformation, relevant for healthcare sustainability policies.
📄 Abstract（原文）
The mounting pressure on the pharmaceutical industry to address issues such as resource consumption, hazardous waste generation, unsustainable packaging, and carbon emissions from drug delivery systems and healthcare operations is growing. Linear production models, centered on extraction, consumption, and disposal, are no longer sufficient to guarantee sustainable environmental outcomes and profitability in the long term. This study investigates how the principles of the circular economy can enhance the profitability and sustainability of pharmaceutical drug delivery systems by integrating green leadership and environmental accounting. The study is conceptual and secondary in nature, drawing on open-access academic literature, sustainability reports, and publications by institutions related to the circular economy, pharmaceutical sustainability, environmental management, and green organizational practices. The results show that implementing the circular economy reduces waste, optimizes resources, enables sustainable supply chain management, and supports efficient operation in pharmaceutical systems. The study also emphasizes that green leadership is an important factor in fostering green organizational culture and strategic environmental decision-making, and environmental accounting facilitates sustainability measurement, cost analysis, and profitability evaluation. The research offers an integrated sustainability framework based on the findings, which involves both circular economy practices and green leadership, environmental accounting, sustainability innovation, and stakeholder engagement, aiming to enhance environmental performance and sustainable profitability. The study finds that sustainable pharmaceutical transformation can create substantial economic, environmental, and strategic advantages, ensure regulatory compliance, and promote healthcare sustainability goals. The framework proposed in this work is a contribution to the literature on sustainability, as it provides a holistic model dedicated to drug delivery systems in the pharmaceutical sector.
🔗 Provenance — このレコードを発見したソース
- semanticscholar https://doi.org/10.25258/ijddt.16.49s.39first seen 2026-06-04 05:05:31 · last seen 2026-06-16 05:01:20
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。